Highlights
MWC technical excellence helps NZ attract new medicines
A high profile paper has highlighted the growing support the MWC is providing to NZ’s burgeoning clinical trials sector.
read the full story
MWC continues to lead the way in NZ cancer vaccine research
Immune therapy is one of the most exciting and promising areas of cancer research. Around New Zealand, teams of Maurice Wilki...
read the full story
New imaging improves our understanding of the immune system
Maurice Wilkins Centre researchers have used novel imaging technology to reveal the structure and inner workings of entire ly...
read the full story
Chemistry, bio and immunology combine to target immune receptor
A Maurice Wilkins Centre collaboration across several scientific disciplines has led to a patent for a new immunotherapy drug...
read the full story
Newly funded research highlights MWC collaborations
A five-year research programme aims to develop nontoxic vaccine technologies to complement existing cancer immunotherapies.
read the full story
MWC leads cancer immune therapy conversation
The Maurice Wilkins Centre continues to be part of an international drive to develop and improve immune therapy for cancer. I...
read the full story